PAVmed (PAVM) Other Operating Expenses (2020 - 2025)

PAVmed's Other Operating Expenses history runs 6 years deep, the most recent figure standing at $3.9 million for Q4 2025.

• On a quarterly basis, Other Operating Expenses rose 1825.62% year-over-year to $3.9 million in Q4 2025; TTM through Dec 2025 was $5.6 million, a 45.53% decrease from a year earlier, with the FY2025 full-year figure at $4.7 million, down 72.34% from the prior year.
• Other Operating Expenses advanced to $3.9 million in Q4 2025 per PAVM's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $14.9 million in Q4 2021 and bottomed at $203000.0 in Q4 2024.
• The 5-year median for Other Operating Expenses is $3.3 million (2022), against an average of $4.0 million.
• Biggest YoY gain for Other Operating Expenses was 1825.62% in 2025; the steepest drop was 95.66% in 2025.
• Year by year, Other Operating Expenses stood at $14.9 million in 2021, then plunged by 81.3% to $2.8 million in 2022, then slumped by 64.0% to $1.0 million in 2023, then slumped by 79.7% to $203000.0 in 2024, then jumped by 1825.62% to $3.9 million in 2025.
• Per Business Quant, the three latest PAVM Other Operating Expenses figures stand at $3.9 million (Q4 2025), $1.1 million (Q3 2025), and $261000.0 (Q2 2025).